Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-307204

Chief Executive Officer sold 40,000 shares at $79.77 ($3,190,796)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BELANOFF JOSEPH K · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-01 Sale : show line 1 in the form 10b5-1 −40,000 $79.77 $3,190,796 2,701,370 I
Open-market sales · 40,000 sh · avg $79.77 · $3,190,796
Loading xslF345X05/ownership.xml…